Literature DB >> 18614512

Incidence of bullous pemphigoid and pemphigus vulgaris.

Pascal Joly.   

Abstract

Mesh：

Year:  2008        PMID： 18614512      PMCID： PMC2483881          DOI： 10.1136/bmj.a209

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Prediction of survival for patients with bullous pemphigoid: a prospective study.

Authors:  Pascal Joly; Jacques Benichou; Catherine Lok; Marie France Hellot; Philippe Saiag; Emmanuelle Tancrede-Bohin; Bruno Sassolas; Bruno Labeille; Marie Sylvie Doutre; Isabelle Gorin; Christine Pauwels; Olivier Chosidow; Frédéric Caux; Eric Estève; Yves Dutronc; Michèle Sigal; Catherine Prost; Hervé Maillard; Jean Claude Guillaume; Jean Claude Roujeau
Journal:  Arch Dermatol       Date:  2005-06

2.  High risk of death in elderly patients with extensive bullous pemphigoid.

Authors:  J C Roujeau; C Lok; S Bastuji-Garin; S Mhalla; V Enginger; P Bernard
Journal:  Arch Dermatol       Date:  1998-04

3.  A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

Authors:  Pascal Joly; Jean-Claude Roujeau; Jacques Benichou; Catherine Picard; Brigitte Dreno; Emmanuel Delaporte; Loic Vaillant; Michel D'Incan; Patrice Plantin; Christophe Bedane; Paul Young; Philippe Bernard
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

4.  Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.

Authors:  V S Gudi; M I White; N Cruickshank; R Herriot; S L Edwards; F Nimmo; A D Ormerod
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

5.  Neurological disorders in patients with bullous pemphigoid.

Authors:  Nadège Cordel; Olivier Chosidow; Marie-France Hellot; Emmanuel Delaporte; Catherine Lok; Loïc Vaillant; Philippe Bernard; Michel D'Incan; Jean Claude Roujeau; Pascal Joly
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

6.  Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

Authors:  Berthold Rzany; Karin Partscht; Martin Jung; Werner Kippes; Dieter Mecking; Bozena Baima; Christin Prudlo; Beata Pawelczyk; Elisabeth M Messmer; Monika Schuhmann; Ronald Sinkgraven; Lutz Büchner; Lioba Büdinger; Christine Pfeiffer; Michael Sticherling; Michael Hertl; Hans-Wilhelm Kaiser; Michael Meurer; Detlef Zillikens; Gerald Messer
Journal:  Arch Dermatol       Date:  2002-07

7.  A single cycle of rituximab for the treatment of severe pemphigus.

Authors:  Pascal Joly; Hugo Mouquet; Jean-Claude Roujeau; Michel D'Incan; Danièle Gilbert; Serge Jacquot; Marie-Lise Gougeon; Christophe Bedane; Ralf Muller; Brigitte Dreno; Marie-Sylvie Doutre; Emmanuel Delaporte; Christine Pauwels; Nathalie Franck; Frédéric Caux; Catherine Picard; Emmanuelle Tancrede-Bohin; Philippe Bernard; François Tron; Michael Hertl; Philippe Musette
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

8.  Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.

Authors:  S M Langan; L Smeeth; R Hubbard; K M Fleming; C J P Smith; J West
Journal:  BMJ       Date:  2008-07-09
  8 in total
  2 in total

1.  The incidence of bullous pemphigoid continues to increase in England.

Authors:  C E Bax; V P Werth
Journal:  Br J Dermatol       Date:  2020-06-15       Impact factor: 9.302

Review 2.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.